|
Volumn 52, Issue 1, 1999, Pages 216-217
|
111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases [3] (multiple letters)
a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
METHOTREXATE;
PENTETATE INDIUM IN 113M;
STEROID;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
INDIUM;
OCTREOTIDE;
PENTETIC ACID;
SDZ 215 811;
SDZ 215-811;
ASEPTIC MENINGITIS;
BRAIN METASTASIS;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CEREBROSPINAL FLUID FLOW;
CLINICAL TRIAL;
DRUG DISTRIBUTION;
HUMAN;
INTRATHECAL DRUG ADMINISTRATION;
LEPTOMENINX;
LETTER;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
STEROID THERAPY;
CEREBROSPINAL FLUID;
INTRASPINAL DRUG ADMINISTRATION;
MENINGIOMA;
METASTASIS;
NOTE;
PHYSIOLOGY;
SCINTISCANNING;
ANTINEOPLASTIC AGENTS;
CEREBROSPINAL FLUID;
HUMANS;
INDIUM RADIOISOTOPES;
INJECTIONS, SPINAL;
MENINGEAL NEOPLASMS;
OCTREOTIDE;
PENTETIC ACID;
|
EID: 0032621651
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (52)
|
References (0)
|